Intra-vitreal injections or implants

FOI REFERENCE: 24366    FOI DATE: 13^th September 2024     

Request & Response:

How many of the following intra-vitreal injections/implants has your Trust administered in the four-month period from May to August 2024:

• Aflibercept  1,552
• Bevacizumab – Avastin  94
• Brolucizumab  0
• Bevacizumab – Biosimilar 0
• Dexamethasone  110
• Faricimab  282
• Fluocinolone acetonide  7
• Ranibizumab – Lucentis (pre-filled syringes)  7
• Ranibizumab – Lucentis (vials)   0
• Ranibizumab – Ongavia   335
• Ranibizumab – Ximluci    0